Press and Knowledge Center
Learn more about Karen’s fight to enter a clinical trial and why we’re so passionate about helping other patients of color do the same.
See how Karen’s Club is joining the global conversation about cancer research, via Bloomberg.
The IO Clinical Trial Gap in the Black Patient Population: It’s Time to Sound the Alarm
The Imperative of Inclusion (BBC Storyworks)
5 lessons in healthcare innovation
Patient Facing Grim Prognosis Finds Her Way to Perlmutter Cancer Center & Makes Medical History
Read on nyulangone.org >
This Woman With Metastatic Breast Cancer Did Her Own Research to Find a Clinical Trial to Fight the Disease
When Beating Cancer Means Battling the System
Self-advocacy saved her life: Black Harlem woman sought her own cancer treatment in face of racial health care disparities
The Importance of Grassroots Health Advocacy and Lay Navigation in Communities of Color
Taking Patient Advocacy for Cancer Clinical Trials to a New Level
Karen’s Immunotherapy Story: Empowerment Through Education
Read on cancerresearch.org >
Karen Peterson Survived Breast Cancer By Doing Her Own Research
I Let Science, Not Emotion, Dictate My Treatment.
Biden Cancer Initiative Announces the Oncology Clinical Trial Information Commons
How Clinical Trials Are Failing All of Us—Especially Black Patients
How an IO Patient Created an Organization to Empower Patients of Color
Karen Peterson: Surviving Breast Cancer Thanks to a Clinical Trial
Watch the interview on Youtube >
New York Woman, 54, with Stage 4 Breast Cancer 'Won't Stop Fighting' for a Cure
Pushing for the Best Possible Treatment for My Stage 4 Breast Cancer
Triple-Negative Breast Cancer Survivor: Survivor Forges Own Path and Helps Others
The AACR Cancer Disparities Progress Report 2020: Achieving the Bold Vision of Health Equity for Racial and Ethnic Minorities and Other Underserved Populations.
Join the Club.
Whether on not you’re ready to talk, we’d love to have you. Stay on top of new ways we’ll be supporting patients of color to seek the best care.